{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T10:56:47Z","timestamp":1789642607938,"version":"4.0.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jogc.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Obstetrics and Gynaecology Canada"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.jogc.2017.01.032","type":"journal-article","created":{"date-parts":[[2017,8,30]],"date-time":"2017-08-30T08:17:02Z","timestamp":1504081022000},"page":"805-817","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":120,"title":["RETIRED: No. 348-Joint SOGC-CCMG Guideline: Update on Prenatal Screening for Fetal Aneuploidy, Fetal Anomalies, and Adverse Pregnancy Outcomes"],"prefix":"10.1016","volume":"39","author":[{"given":"Francois","family":"Audibert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"De Bie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo-Ann","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanette","family":"Okun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Douglas","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Armour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Chitayat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jogc.2017.01.032_bib1","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1701-2163(15)31025-2","article-title":"Current status in non-invasive prenatal detection of Down syndrome, trisomy 18, and trisomy 13 using cell-free DNA in maternal plasma","volume":"35","author":"Langlois","year":"2013","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2017.01.032_bib2","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/S1701-2163(16)32973-5","article-title":"Obstetrical complications associated with abnormal maternal serum markers analytes","volume":"30","author":"Gagnon","year":"2008","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2017.01.032_bib3","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S1701-2163(16)30720-4","article-title":"Fetal soft markers in obstetric ultrasound","volume":"27","author":"Van den Hof","year":"2005","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2017.01.032_bib4","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S1701-2163(16)34961-1","article-title":"Prenatal screening for fetal aneuploidy in singleton pregnancies","volume":"33","author":"Chitayat","year":"2011","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2017.01.032_bib5","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/S1701-2163(16)34963-5","article-title":"Prenatal screening for and diagnosis of aneuploidy in twin pregnancies","volume":"33","author":"Audibert","year":"2011","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2017.01.032_bib6","first-page":"363","article-title":"Noninvasive prenatal testing and fetal sonographic screening: roundtable discussion","volume":"34","author":"Yagel","year":"2015","journal-title":"J\u00a0Ultrasound Med"},{"key":"10.1016\/j.jogc.2017.01.032_bib7","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/uog.13393","article-title":"ISUOG consensus statement on the impact of non-invasive prenatal testing (NIPT) on prenatal ultrasound practice","volume":"44","author":"Salomon","year":"2014","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.jogc.2017.01.032_bib8","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S1701-2163(15)30664-2","article-title":"Determination of gestational age by ultrasound","volume":"36","author":"Butt","year":"2014","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2017.01.032_bib9","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/uog.12513","article-title":"Non-invasive prenatal testing for aneuploidy: current status and future prospects","volume":"42","author":"Benn","year":"2013","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.jogc.2017.01.032_bib10","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/uog.14791","article-title":"Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis","volume":"45","author":"Gil","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.jogc.2017.01.032_bib11","doi-asserted-by":"crossref","first-page":"365e1","DOI":"10.1016\/j.ajog.2014.03.042","article-title":"Noninvasive prenatal screening for fetal trisomies 21, 18, 13 and the common sex chromosome aneuploidies from maternal blood using massively parallel genomic sequencing of DNA","volume":"211","author":"Porreco","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogc.2017.01.032_bib12","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1159\/000264259","article-title":"Maternal age and gestational age-specific risk for chromosomal defects","volume":"10","author":"Snijders","year":"1995","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.jogc.2017.01.032_bib13","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/uog.13388","article-title":"Non-invasive prenatal testing for trisomy 13: more harm than good?","volume":"44","author":"Verweij","year":"2014","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.jogc.2017.01.032_bib14","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1097\/AOG.0000000000001051","article-title":"Committee Opinion No. 640: Cell-free DNA screening for fetal aneuploidy","volume":"126","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2017.01.032_bib15","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/pd.4666","article-title":"Recommended pre-test counseling points for noninvasive prenatal testing using cell-free DNA: a 2015 perspective","volume":"35","author":"Sachs","year":"2015","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.jogc.2017.01.032_bib16","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/uog.12331","article-title":"Fetal fraction in maternal plasma cell-free DNA at 11-13 weeks\u2019 gestation: relation to maternal and fetal characteristics","volume":"41","author":"Ashoor","year":"2013","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.jogc.2017.01.032_bib17","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/pd.4126","article-title":"The impact of maternal plasma DNA fetal fraction on next generation sequencing tests for common fetal aneuploidies","volume":"33","author":"Canick","year":"2013","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.jogc.2017.01.032_bib18","doi-asserted-by":"crossref","first-page":"e88484","DOI":"10.1371\/journal.pone.0088484","article-title":"Maternal plasma fetal DNA fractions in pregnancies with low and high risks for fetal chromosomal aneuploidies","volume":"9","author":"Hudecova","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jogc.2017.01.032_bib19","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1038\/oby.2012.138","article-title":"Increased death of adipose cells, a path to release cell-free DNA into systemic circulation of obese women","volume":"20","author":"Haghiac","year":"2012","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.jogc.2017.01.032_bib20","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1097\/AOG.0b013e31824fb482","article-title":"Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing","volume":"119","author":"Bianchi","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2017.01.032_bib21","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/GIM.0b013e3182368a0e","article-title":"DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study","volume":"13","author":"Palomaki","year":"2011","journal-title":"Genet Med"},{"key":"10.1016\/j.jogc.2017.01.032_bib22","doi-asserted-by":"crossref","first-page":"137e1","DOI":"10.1016\/j.ajog.2012.05.021","article-title":"Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18","volume":"207","author":"Norton","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogc.2017.01.032_bib23","first-page":"31","article-title":"Six consecutive false positive cases from cell-free fetal DNA testing in a single referring centre","volume":"8","author":"Dugo","year":"2014","journal-title":"J\u00a0Prenat Med"},{"key":"10.1016\/j.jogc.2017.01.032_bib24","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/gim.2013.26","article-title":"Positive cell-free fetal DNA testing for trisomy 13 reveals confined placental mosaicism","volume":"15","author":"Hall","year":"2013","journal-title":"Genet Med"},{"key":"10.1016\/j.jogc.2017.01.032_bib25","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/pd.4076","article-title":"Secondary findings from non-invasive prenatal testing for common fetal aneuploidies by whole genome sequencing as a clinical service","volume":"33","author":"Lau","year":"2013","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.jogc.2017.01.032_bib26","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1373\/clinchem.2013.215145","article-title":"Maternal mosaicism is a significant contributor to discordant sex chromosomal aneuploidies associated with noninvasive prenatal testing","volume":"60","author":"Wang","year":"2014","journal-title":"Clin Chem"},{"key":"10.1016\/j.jogc.2017.01.032_bib27","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1002\/pd.3946","article-title":"Noninvasive prenatal genetic testing for fetal aneuploidy detects maternal trisomy X.","volume":"32","author":"Yao","year":"2012","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.jogc.2017.01.032_bib28","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJMoa1408408","article-title":"Copy-number variation and false positive prenatal aneuploidy screening results","volume":"372","author":"Snyder","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jogc.2017.01.032_bib29","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/pd.4100","article-title":"Discordant noninvasive prenatal testing results in a patient subsequently diagnosed with metastatic disease","volume":"33","author":"Osborne","year":"2013","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.jogc.2017.01.032_bib30","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1001\/jama.2015.7120","article-title":"Noninvasive prenatal testing and incidental detection of occult maternal malignancies","volume":"314","author":"Bianchi","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.jogc.2017.01.032_bib31","doi-asserted-by":"crossref","first-page":"79e1","DOI":"10.1016\/j.ajog.2014.10.012","article-title":"Detection of triploid, molar, and vanishing twin pregnancies by a single-nucleotide polymorphism-based noninvasive prenatal test","volume":"212","author":"Curnow","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogc.2017.01.032_bib32","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1136\/jmg.33.7.529","article-title":"Confined placental mosaicism","volume":"33","author":"Kalousek","year":"1996","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.jogc.2017.01.032_bib33","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/(SICI)1096-8628(19970516)70:2<179::AID-AJMG15>3.0.CO;2-G","article-title":"European collaborative research on mosaicism in CVS (EUCROMIC)\u2014fetal and extrafetal cell lineages in 192 gestations with CVS mosaicism involving single autosomal trisomy","volume":"70","author":"Hahnemann","year":"1997","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.jogc.2017.01.032_bib34","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/humrep\/deh117","article-title":"Circulating cell-free fetal DNA in maternal serum appears to originate from cyto- and syncytio-trophoblastic cells. Case report","volume":"19","author":"Flori","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jogc.2017.01.032_bib35","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1002\/pd.4659","article-title":"The type of feto-placental aneuploidy detected by cfDNA testing may influence the choice of confirmatory diagnostic procedure","volume":"35","author":"Grati","year":"2015","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.jogc.2017.01.032_bib36","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1159\/000356495","article-title":"Cell-free DNA analysis for trisomy risk assessment in first-trimester twin pregnancies","volume":"35","author":"del Mar Gil","year":"2014","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.jogc.2017.01.032_bib37","doi-asserted-by":"crossref","first-page":"332e1","DOI":"10.1016\/j.ajog.2014.11.041","article-title":"Expanding the scope of noninvasive prenatal testing: detection of fetal microdeletion syndromes","volume":"212","author":"Wapner","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogc.2017.01.032_bib38","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1056\/NEJMoa1203382","article-title":"Chromosomal microarray versus karyotyping for prenatal diagnosis","volume":"367","author":"Wapner","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jogc.2017.01.032_bib39","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1097\/AOG.0000000000000237","article-title":"Noninvasive prenatal testing for microdeletion syndromes and expanded trisomies: proceed with caution","volume":"123","author":"Vora","year":"2014","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2017.01.032_bib40","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/pd.4640","article-title":"Clinical outcome of subchromosomal events detected by whole-genome noninvasive prenatal testing","volume":"35","author":"Helgeson","year":"2015","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.jogc.2017.01.032_bib41","first-page":"578","article-title":"DNA sequencing versus standard prenatal aneuploidy screening","volume":"371","author":"Bianchi","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jogc.2017.01.032_bib42","doi-asserted-by":"crossref","first-page":"214e1","DOI":"10.1016\/j.ajog.2015.04.001","article-title":"Noninvasive prenatal screening for aneuploidy: positive predictive values based on cytogenetic findings","volume":"213","author":"Meck","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogc.2017.01.032_bib43","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/uog.15783","article-title":"Clinical implementation of routine screening for fetal trisomies in the UK NHS: cell-free DNA test contingent on results from first-trimester combined test","volume":"47","author":"Gil","year":"2016","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.jogc.2017.01.032_bib44","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.clinbiochem.2015.02.011","article-title":"Cell-free DNA screening for fetal aneuploidy as a clinical service","volume":"48","author":"Cuckle","year":"2015","journal-title":"Clin Biochem"},{"key":"10.1016\/j.jogc.2017.01.032_bib45","doi-asserted-by":"crossref","first-page":"e93559","DOI":"10.1371\/journal.pone.0093559","article-title":"Model-based analysis of costs and outcomes of non-invasive prenatal testing for Down\u2019s syndrome using cell free fetal DNA in the UK National Health Service","volume":"9","author":"Morris","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jogc.2017.01.032_bib46","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/pd.4311","article-title":"The price of performance: a cost and performance analysis of the implementation of cell-free fetal DNA testing for Down syndrome in Ontario, Canada","volume":"34","author":"Okun","year":"2014","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.jogc.2017.01.032_bib47","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/uog.12364","article-title":"Meta-analysis of second-trimester markers for trisomy 21","volume":"41","author":"Agathokleous","year":"2013","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.jogc.2017.01.032_bib48","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/uog.13228","article-title":"Systematic review and meta-analysis of performance of second-trimester nasal bone assessment in detection of fetuses with Down syndrome","volume":"43","author":"Moreno-Cid","year":"2014","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.jogc.2017.01.032_bib49","doi-asserted-by":"crossref","first-page":"103.e1","DOI":"10.1016\/j.ajog.2015.08.034","article-title":"Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation","volume":"214","author":"O\u2019Gorman","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogc.2017.01.032_bib50","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/pd.4397","article-title":"First-trimester maternal factors and biomarker screening for preeclampsia","volume":"34","author":"Poon","year":"2014","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.jogc.2017.01.032_bib51","doi-asserted-by":"crossref","first-page":"297397","DOI":"10.1155\/2014\/297397","article-title":"Early prediction of preeclampsia","volume":"2014","author":"Poon","year":"2014","journal-title":"Obstet Gynecol Int"},{"key":"10.1016\/j.jogc.2017.01.032_bib52","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S1701-2163(15)30444-8","article-title":"Prenatal screening, diagnosis, and pregnancy management of fetal neural tube defects","volume":"36","author":"Wilson","year":"2014","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2017.01.032_bib53","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/(SICI)1097-0223(199808)18:8<789::AID-PD345>3.0.CO;2-9","article-title":"Steroid sulphatase deficiency is the major cause of extremely low oestriol production at mid-pregnancy: a urinary steroid assay for the discrimination of steroid sulphatase deficiency from other causes","volume":"18","author":"Glass","year":"1998","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.jogc.2017.01.032_bib54","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/pd.1518","article-title":"Identifying Smith-Lemli-Opitz syndrome in conjunction with prenatal screening for Down syndrome","volume":"26","author":"Craig","year":"2006","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.jogc.2017.01.032_bib55","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1136\/jms.9.1.43","article-title":"Assigning risk for Smith-Lemli-Opitz syndrome as part of 2nd trimester screening for Down\u2019s syndrome","volume":"9","author":"Palomaki","year":"2002","journal-title":"J\u00a0Med Screen"},{"key":"10.1016\/j.jogc.2017.01.032_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ajmg.a.30170","article-title":"Undetectable maternal serum uE3 and postnatal abnormal sterol and steroid metabolism in Antley-Bixler syndrome","volume":"129A","author":"Cragun","year":"2004","journal-title":"Am J Med Genet A"}],"updated-by":[{"DOI":"10.1016\/j.jogc.2018.05.039","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000}}],"container-title":["Journal of Obstetrics and Gynaecology Canada"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1701216317300701?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1701216317300701?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T15:11:55Z","timestamp":1778339515000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1701216317300701"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":56,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S1701216317300701"],"URL":"https:\/\/doi.org\/10.1016\/j.jogc.2017.01.032","relation":{},"ISSN":["1701-2163"],"issn-type":[{"value":"1701-2163","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RETIRED: No. 348-Joint SOGC-CCMG Guideline: Update on Prenatal Screening for Fetal Aneuploidy, Fetal Anomalies, and Adverse Pregnancy Outcomes","name":"articletitle","label":"Article Title"},{"value":"Journal of Obstetrics and Gynaecology Canada","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jogc.2017.01.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Society of Obstetricians and Gynaecologists of Canada\/La Soci\u00e9t\u00e9 des obst\u00e9triciens et gyn\u00e9cologues du Canada. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}